Browsing Tag
SoftBank
17 posts
Is Lenskart the Nykaa of eyewear? What its IPO means for India’s D2C brand valuations in 2025
As Lenskart eyes a ₹70,000 crore IPO valuation, investors are asking if it can repeat Nykaa’s playbook for India’s D2C brands. Explore the real comparison.
October 29, 2025
Should you subscribe to the Lenskart IPO at Rs 382–402? Key dates, risks, and long-term outlook
Lenskart’s ₹7,278 crore IPO aims to raise funds at a valuation of nearly $8 billion. Explore key issue details, institutional sentiment, and investor risks.
October 27, 2025
Why DMart founder Radhakishan Damani’s Rs 90 cr bet in Lenskart ahead of IPO is a game‑changer
Find out why DMart’s Radhakishan Damani just bet ₹90 crore on Lenskart ahead of its IPO—and what this means for India’s consumer IPO market.
October 25, 2025
Inside OpenAI’s $25bn bet on Argentina: How the Stargate project could reshape global AI power
OpenAI is planning a $25 billion AI data-center project in Argentina with Sur Energy, marking one of Latin America’s biggest tech investments. Find out what it means for global AI infrastructure.
October 10, 2025
Can PayPay’s 40% stake in Binance Japan unlock the next wave of Web3 adoption in the country?
PayPay’s 40% investment in Binance Japan may reshape Web3 adoption in Japan. Discover how this partnership bridges crypto with everyday finance.
October 10, 2025
Behind the $500bn milestone: How OpenAI turned secondary sales into a global power shift
OpenAI’s $500 billion valuation makes it the world’s most valuable startup. Find out what drove the deal, who invested, and whether the hype is sustainable.
October 2, 2025
Why Intel’s $2bn share sale to SoftBank could reshape the U.S. chipmaker’s turnaround story
Intel sells $2B in stock to SoftBank, raising fresh capital at a turning point for its foundry and AI strategy. Find out what it means for investors.
September 30, 2025
Leyden Labs secures €20m from European Investment Bank: Could this reshape Europe’s pandemic response strategy?
Leyden Labs secures €20M EIB funding under HERA Invest to develop intranasal antibody sprays targeting pandemic flu and respiratory threats.
June 3, 2025
CoreWeave lands $11.9bn AI deal with OpenAI amid IPO speculation
CoreWeave has bagged a $11.9 billion AI infrastructure contract with OpenAI, a move that will significantly enhance the…
March 12, 2025
Stargate Project: Tech giants unite to invest $500bn in US AI infrastructure
In a landmark move set to redefine artificial intelligence (AI) infrastructure, major technology companies have unveiled the Stargate…
January 25, 2025